Abstract:Our aim was to construct the eukaryotic expressional system of single-chain antibody (ScFv(2F9)) derived from a new clone of monoclonal antibody named ZCH-7-2F9 against human CD14 antigen, and to obtain the ScFv(2F9) protein with a high biological activity for further studies on ScFv(2F9) immunotoxin and other kinds of genetically engineered antibodies. Primers were synthesized according to the gene sequence of ScFv(2F9), 4 tandem glysines and 1 serine (Gly4Ser)3 linker and multiple cloning site(MCS) of pSectag2A vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. ScFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Then the gene was cloned to pGEM-T easy and pSectag2A vectors. Positive recombinants (pSectag2A/ScFv(2F9)) were identified through enzyme cleaving and sequenced before expression. The recombinant plasmids were transfected into Chinese hamster ovary (CHO) cells for expression. The relative molecular weight (MW) and the binding activity of the interesting protein were determined by SDS-PAGE, Western-blot and flow cytometry (FCM), respectively. The scFv(2F9) V-H is a member of the IgH gene family V, subgroup and the scFv(2F9) V-L gene belongs to the Ig(k) gene family V-10 subgroup. The recombined ScFv(2F9) gene was identified to be functional by sequencing and expressing. The interesting protein could be detected in the culture supernatant of transformed CHO cells with a MW of 31 kDa. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.3% and 63.38%, respectively after blockage of ScFv(2F9). The ScFv(2F9) gene was cloned and the interest protein against human CD14 antigen has been successfully expressed in eukaryotic cells with a high biological activity, which lays the foundation for further studies on its immunotoxin and other kinds of engineered antibodies.

[Establishment of C26 Cell Strain Stably Expressing Folate Receptor Α].

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

[Serial Recombinant Expression and Anti-Tumor Activity in Vitro of Antibiotic Peptide Alloferon-1].

Successful Construction and Stable Expression of an Anti-Cd45ra Scfv–egfp Fusion Protein in Chinese Hamster Ovary Cells

[Establishment of a Transgenic Cell Line with Stable Expression of Human CD14].

Construction of Eukaryotic Expression Plasmids Containing Green Fluorescent Protein Gene and CYP19 WT or Its Variants

Functional Identification of the Stable Transfection C5ar Cell Line Molt-4

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

Development of a human viable heavy chain antibody against the alpha folate receptor as a molecule for targeted application by phage display technology

Construction, expression and identification of recombinant plasmid encoding bifunctional protein sflk1-IFN-gamma]

Expression and purification of the extracellular domain of the human follicle-stimulating hormone receptor using Escherichia coli

Construction and Identification of Eukaryotic Expression Vector of Folate Binding Proteins 1

Folate Receptor Alpha—A Novel Approach to Cancer Therapy

PREPARATION OF RECOMBINANT PROTEIN OF EXTRACELLULAR LIGAND BINDING DOMAINS OF MOUSE VEGF RECEPTOR 2 AND ITS APPLICATION

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

Protein-Labeling Fluorescent Probe for Folate Receptor α

Combination of FACS and Homologous Recombination for the Generation of Stable and High-Expression Engineered Cell Lines.

Construction of Recombinant FGFR1 Containing Full-Length Gene and Its Potential Application

A Strategy for High-Level Expression of a Single-Chain Variable Fragment Against TNFα by Subcloning Antibody Variable Regions from the Phage Display Vector Pcantab 5E into Pbv220.

An efficient and targeted gene integration system for high-level antibody expression.

[Establishment of Flp-InTM CHO cell lines with double expression of CYP2A13 and MRP2]